In the blood of COVID-19 survivors are antibodies that can defeat SARS-CoV-2. Researchers are testing whether these antibodies can be collected and injected into others to save them from the virus.
Articles on Antibodies
Displaying 81 - 100 of 131 articles
As grim as things are with the pandemic raging in the US and the mounting death toll, there are many reasons to be optimistic there will be a vaccine by early next year.
Some people’s blood can mount an immune response against SARS-CoV-2, even if those blood samples were taken from before the COVID-19 pandemic started.
Researchers can’t agree on topics such face mask, immunity and number of infections. Here’s why.
If immunity is short-lived, we will be in an ongoing cycle of endless reinfection.
There is speculation about whether a population can achieve some sort of immunity to the virus with as little as 20% infected.
If you have had COVID-19 already, are you protected from another bout of the illness? And is the presence of antibodies in your blood a guarantee of immunity?
The antibody can be used to diagnose Alzheimer’s disease.
Tobacco has imposed a terrible toll on global health, but it could be used to produce the molecules we need to fight COVID-19.
Antibodies that recognize and block SARS-CoV-2 infection have the potential to be powerful weapons. An infectious disease expert explains what antibodies are and how they could be used as a therapy.
Our experts look at recovery efforts, how different the post-pandemic world will be, the hunt for a cure for COVID-19, and why we need to mind our mental health.
An antigen test was given emergency use authorization by the FDA in early May. A biochemist explains how COVID-19 antigen tests work.
Amazon and General Motors are among companies exploring ways to test employees for COVID-19 infection, but these measures may be against the law.
Immunity to COVID-19 may be complicated. Here are the promises and pitfalls of antibody tests.
‘Nanobodies’ produced by the llama immune system can neutralise the virus that causes COVID-19.
Immunity passports have been touted as a way to reopen the economy. But there are serious concerns they’ll create an incentive to intentionally contract the coronavirus.
Nearly two million antibody tests imported into Australia can’t be used to diagnose COVID-19. But it’s difficult to make an antibody test that is specific and sensitive enough.
A biomedical researcher and pediatrician who works with Kawasaki disease and COVID-19 explains the similarities and differences in the worrisome cases doctors are starting to see.
Expanding coronavirus testing is one of the most important tasks public health officials are tackling right now. But questions over accuracy of the two main types of tests have rightly caused concern.
The science is far from certain, but it appears at least a proportion of people who have had COVID-19 will be protected from another infection – at least initially.
Top contributors
-
Professor of Medicine, University of Virginia
-
Instructor of Human Immunology, Emory University
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Research Fellow, Institute for Molecular Bioscience, The University of Queensland
-
Associate Professor of Biology, Rochester Institute of Technology
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Senior Lecturer; MD, Victoria University
-
Emeritus Professor, Brunel University of London
-
Senior Lecturer in Biomedical Sciences, Brunel University of London
-
Program Director, Infectious Diseases and Immunology, Menzies Health Institute, Griffith University
-
Professor, Biomedicine Discovery Institute, Monash University
-
Associate Professor of Molecular Medicine, UMass Chan Medical School
-
Assistant Professor of Medicine, University of Virginia
-
Distinguished Professor, Professor of Immunology, RMIT University